$AGEN
AGENUS INC

2024 Q4 Form 10-Q Financial Statement

#000095017024125608 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $25.11M
YoY Change 3.28%
Cost Of Revenue $146.0K
YoY Change -51.82%
Gross Profit $24.97M
YoY Change 3.98%
Gross Profit Margin 99.42%
Selling, General & Admin $17.28M
YoY Change -8.6%
% of Gross Profit 69.19%
Research & Development $41.06M
YoY Change -20.19%
% of Gross Profit 164.46%
Depreciation & Amortization $3.346M
YoY Change 17.4%
% of Gross Profit 13.4%
Operating Expenses $41.06M
YoY Change -20.19%
Operating Profit -$31.50M
YoY Change -32.02%
Interest Expense -$35.73M
YoY Change 91.75%
% of Operating Profit
Other Income/Expense, Net $19.00K
YoY Change -95.7%
Pretax Income -$67.21M
YoY Change 4.21%
Income Tax
% Of Pretax Income
Net Earnings -$67.21M
YoY Change 4.16%
Net Earnings / Revenue -267.66%
Basic Earnings Per Share -$3.08
Diluted Earnings Per Share -$3.08
COMMON SHARES
Basic Shares Outstanding 23.46M 21.57M
Diluted Shares Outstanding 21.55M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.78M
YoY Change -57.87%
Cash & Equivalents $44.78M
Short-Term Investments
Other Short-Term Assets $2.811M
YoY Change 20.7%
Inventory
Prepaid Expenses $2.352M
Receivables $207.0K
Other Receivables $0.00
Total Short-Term Assets $50.15M
YoY Change -60.05%
LONG-TERM ASSETS
Property, Plant & Equipment $124.5M
YoY Change -10.89%
Goodwill $24.69M
YoY Change 0.11%
Intangibles $3.955M
YoY Change -12.05%
Long-Term Investments
YoY Change
Other Assets $6.595M
YoY Change -40.38%
Total Long-Term Assets $188.3M
YoY Change -10.29%
TOTAL ASSETS
Total Short-Term Assets $50.15M
Total Long-Term Assets $188.3M
Total Assets $238.5M
YoY Change -28.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.90M
YoY Change 12.3%
Accrued Expenses $36.70M
YoY Change -2.48%
Deferred Revenue $10.00K
YoY Change -99.8%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $13.40M
YoY Change 3362.79%
Total Short-Term Liabilities $270.6M
YoY Change 36.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $777.0K
YoY Change -90.65%
Total Long-Term Liabilities $777.0K
YoY Change -96.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $270.6M
Total Long-Term Liabilities $777.0K
Total Liabilities $271.4M
YoY Change 23.72%
SHAREHOLDERS EQUITY
Retained Earnings -$2.100B
YoY Change 10.53%
Common Stock $217.0K
YoY Change -94.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$292.3M
YoY Change
Total Liabilities & Shareholders Equity $238.5M
YoY Change -28.91%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$67.21M
YoY Change 4.16%
Depreciation, Depletion And Amortization $3.346M
YoY Change 17.4%
Cash From Operating Activities -$53.29M
YoY Change -18.3%
INVESTING ACTIVITIES
Capital Expenditures $7.000K
YoY Change -99.8%
Acquisitions
YoY Change
Other Investing Activities $63.00K
YoY Change -99.58%
Cash From Investing Activities $56.00K
YoY Change -99.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.557M
YoY Change -74.74%
NET CHANGE
Cash From Operating Activities -53.29M
Cash From Investing Activities 56.00K
Cash From Financing Activities 4.557M
Net Change In Cash -48.68M
YoY Change 36.59%
FREE CASH FLOW
Cash From Operating Activities -$53.29M
Capital Expenditures $7.000K
Free Cash Flow -$53.30M
YoY Change -22.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001098972
dei Entity Registrant Name
EntityRegistrantName
AGENUS INC
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-29089
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1562417
dei Entity Address Address Line1
EntityAddressAddressLine1
3 Forbes Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Lexington
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02421
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
674-4400
dei Security12b Title
Security12bTitle
Common stock, par value $0.01
dei Trading Symbol
TradingSymbol
AGEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23458929
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44784000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76110000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
207000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25836000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2352000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8098000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2811000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2372000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
50154000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
112416000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
71109000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61943000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124472000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133421000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28612000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29606000
CY2024Q3 us-gaap Goodwill
Goodwill
24694000
CY2023Q4 us-gaap Goodwill
Goodwill
24723000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18063000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17688000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3955000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4411000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6595000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9336000
CY2024Q3 us-gaap Assets
Assets
238482000
CY2023Q4 us-gaap Assets
Assets
313913000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
13401000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
146000
CY2024Q3 agen Liability Related To Sale Of Future Royalties And Milestones Payment Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent
159647000
CY2023Q4 agen Liability Related To Sale Of Future Royalties And Milestones Payment Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent
132502000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2427000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2587000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
45899000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61446000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36695000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45283000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12565000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13915000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
270644000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
255897000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12768000
CY2024Q3 agen Liability Related To Sale Of Future Royalties And Milestones Payment Non Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent
182558000
CY2023Q4 agen Liability Related To Sale Of Future Royalties And Milestones Payment Non Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent
124556000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1143000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1143000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
55164000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62511000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
777000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5420000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21685192
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21685192
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19718662
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19718662
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
217000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
197000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1845815000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1796095000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1347000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-955000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2137021000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1955668000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-292336000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-160331000
CY2024Q3 us-gaap Minority Interest
MinorityInterest
20532000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
11949000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-271804000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-148382000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
238482000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
313913000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25112000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24314000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76626000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72513000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
146000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
303000
us-gaap Cost Of Revenue
CostOfRevenue
368000
us-gaap Cost Of Revenue
CostOfRevenue
2851000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41058000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51443000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121753000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
167846000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17275000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18909000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50947000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57562000
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1863000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1863000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
398000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31504000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-46341000
us-gaap Operating Income Loss
OperatingIncomeLoss
-94579000
us-gaap Operating Income Loss
OperatingIncomeLoss
-155348000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
442000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6054000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
238000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-35729000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18633000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-96940000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-53745000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-67214000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-64532000
us-gaap Profit Loss
ProfitLoss
-185465000
us-gaap Profit Loss
ProfitLoss
-208855000
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
54000
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
53000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
161000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
160000
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-828000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2331000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4112000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9384000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66440000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62254000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-181514000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-199631000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.08
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.29
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.43
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21550000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21550000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18908000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18908000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20995000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20995000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17458000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17458000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-346000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-311000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-392000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1943000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-346000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-311000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-392000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1943000
CY2024Q3 agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-66786000
CY2023Q3 agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-62565000
agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-181906000
agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-201574000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-148382000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-63454000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-116000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4196000
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17171000
CY2024Q1 agen Shares Issued To Payroll In Value
SharesIssuedToPayrollInValue
89000
CY2024Q1 agen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
173000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-190323000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-54797000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
70000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9290000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1990000
CY2024Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
6983000
CY2024Q2 agen Shares Issued To Payroll In Value
SharesIssuedToPayrollInValue
114000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-220839000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-67214000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-346000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9280000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6776000
CY2024Q3 agen Shares Issued To Payroll In Value
SharesIssuedToPayrollInValue
98000
CY2024Q3 agen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
441000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-271804000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-54902000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-70893000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5485000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60583000
CY2023Q1 agen Stock Issued During Period Value Director Deferred Shares
StockIssuedDuringPeriodValueDirectorDeferredShares
983000
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
318000
CY2023Q1 agen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
374000
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
726000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1796000
CY2023Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
2419000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-53109000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-73430000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1634000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6042000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42247000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
235000
CY2023Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
285000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1438000
CY2023Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
1635000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-76761000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-64532000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-311000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5536000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20350000
CY2023Q3 agen Shares Issued To Payroll In Value
SharesIssuedToPayrollInValue
32000
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
328000
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
312000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
410000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-115292000
us-gaap Profit Loss
ProfitLoss
-185465000
us-gaap Profit Loss
ProfitLoss
-208855000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10083000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8387000
us-gaap Share Based Compensation
ShareBasedCompensation
12716000
us-gaap Share Based Compensation
ShareBasedCompensation
17408000
agen Non Cash Royalty Revenue
NonCashRoyaltyRevenue
75006000
agen Non Cash Royalty Revenue
NonCashRoyaltyRevenue
61534000
agen Non Cash Interest Expense
NonCashInterestExpense
97459000
agen Non Cash Interest Expense
NonCashInterestExpense
55977000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-18000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-49000
agen Gain Loss On Lease Terminations
GainLossOnLeaseTerminations
5334000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2638000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-183000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25613000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1308000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5751000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1765000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13682000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
915000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7269000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1722000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
12518000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
893000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1122000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129663000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-183800000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
503000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9731000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
24000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
350000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
5396000
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
527000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
14647000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
30000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
48000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
576000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
25937000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
123179000
agen Proceeds From Sale Of Subsidiary Shares In Private Placement
ProceedsFromSaleOfSubsidiarySharesInPrivatePlacement
5800000
agen Proceeds From Purchase Agreement Net Of Expenses
ProceedsFromPurchaseAgreementNetOfExpenses
73851000
agen Proceeds From Employee Stock Purchases And Option Exercises
ProceedsFromEmployeeStockPurchasesAndOptionExercises
648000
agen Proceeds From Employee Stock Purchases And Option Exercises
ProceedsFromEmployeeStockPurchasesAndOptionExercises
807000
agen Purchase Of Treasury Shares To Satisfy Tax Withholdings
PurchaseOfTreasurySharesToSatisfyTaxWithholdings
4566000
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
564000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7766000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6305000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98470000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
112551000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-216000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-696000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31361000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71369000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
79779000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181343000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48418000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109974000
us-gaap Interest Paid Net
InterestPaidNet
1737000
us-gaap Interest Paid Net
InterestPaidNet
2532000
agen Insurance Financing Agreement
InsuranceFinancingAgreement
771000
agen Insurance Financing Agreement
InsuranceFinancingAgreement
707000
agen Issuance Of Stock Options For Payment Employee Bonuses
IssuanceOfStockOptionsForPaymentEmployeeBonuses
9321000
agen Stock Issued For Subsidiary Employee Bonus
StockIssuedForSubsidiaryEmployeeBonus
1011000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
105000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
318000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
122000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
4812000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44800000
CY2023 agen Decrease In Cash And Cash Equivalents
DecreaseInCashAndCashEquivalents
-31300000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2100000000
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
44800000
CY2023Q3 agen Percentage Of Reduced Workforce
PercentageOfReducedWorkforce
0.25
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Goodwill
Goodwill
24723000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-29000
CY2024Q3 us-gaap Goodwill
Goodwill
24694000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2057000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2057000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22018000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18063000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3955000
CY2023 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2057000
CY2023 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2057000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
22099000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17688000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4411000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
100000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
500000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
500000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
400000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
300000
CY2024Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
337000
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
13401000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
12914000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13500000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13100000
CY2023Q4 agen Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts
257296000
agen Proceeds From Sale Of Future Royalties And Milestones
ProceedsFromSaleOfFutureRoyaltiesAndMilestones
63879000
agen Noncash Royalty Revenue Recognized
NoncashRoyaltyRevenueRecognized
75006000
agen Non Cash Interest Expense Related To Sale Of Future Royalties
NonCashInterestExpenseRelatedToSaleOfFutureRoyalties
97240000
CY2024Q3 agen Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts
343409000
CY2024Q3 agen Liability Related To Sale Of Future Royalties Unamortized Transaction Costs
LiabilityRelatedToSaleOfFutureRoyaltiesUnamortizedTransactionCosts
1204000
CY2024Q3 agen Liability Related To Sale Of Future Royalties And Milestones Net
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesNet
342205000
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
10501000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
14512000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5183000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7101000
CY2024Q3 agen Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
5558000
CY2023Q4 agen Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
7613000
CY2024Q3 agen Accrued Research Services Current
AccruedResearchServicesCurrent
8162000
CY2023Q4 agen Accrued Research Services Current
AccruedResearchServicesCurrent
10807000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7291000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5250000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36695000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45283000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7398000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10457000
CY2024Q3 agen Purchaser Upsize Option
PurchaserUpsizeOption
2161000
CY2024Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3006000
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3458000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12565000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13915000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
7500000
us-gaap Lessee Finance Lease Description
LesseeFinanceLeaseDescription
through September 2025
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
42886000
CY2024Q3 agen Long Term Investments Fair Value Disclosure
LongTermInvestmentsFairValueDisclosure
1499000
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
44385000
CY2024Q3 agen Purchaser Upsize Option Liability Fair Value Disclosure
PurchaserUpsizeOptionLiabilityFairValueDisclosure
2161000
CY2024Q3 agen Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
318000
CY2024Q3 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
2479000
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
70485000
CY2023Q4 agen Long Term Investments Fair Value Disclosure
LongTermInvestmentsFairValueDisclosure
3222000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
73707000
CY2023Q4 agen Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
318000
CY2023Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
318000
CY2024Q3 agen Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
300000
CY2023Q4 agen Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
300000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13500000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13100000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25112000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24314000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76626000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72513000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1161000
agen Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
6000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1153000
CY2024Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2141360
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1370416
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.81
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16668
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
67929
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
27.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
113760
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
63.61
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3313419
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
111
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3313419
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
44.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y2M23D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
111
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2465909
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
50.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.8
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
27163
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
37.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
41452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
17002
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
28.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
15500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
21.39
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
36113
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.52
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9280000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5536000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22766000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17063000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3600000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3700000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76110000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44784000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
178674000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106305000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3669000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3634000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2669000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3669000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
79779000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48418000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181343000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109974000
CY2024Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-125608-index-headers.html Edgar Link pending
0000950170-24-125608-index.html Edgar Link pending
0000950170-24-125608.txt Edgar Link pending
0000950170-24-125608-xbrl.zip Edgar Link pending
agen-20240930.htm Edgar Link pending
agen-20240930.xsd Edgar Link pending
agen-ex31_1.htm Edgar Link pending
agen-20240930_htm.xml Edgar Link completed
agen-ex31_2.htm Edgar Link pending
agen-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending